United States Login

North America

South America

Europe

Middle East / Africa

Asia / Pacific

Global Customer Support

×

Search

×

BDX Stock Price

Volume
52 Week High
52 Week Low

Copyright West LLC. Minimum 15 minutes delayed.
Stock Chart

Investors Overview

SEC Filings / Section 16 Reports

Investor E-mail Alert Service: You can automatically receive Press Release alerts via e-mail by subscribing now.

Filing date	Form	Description	Filing Group	View
02/14/2020	SC 13G/A	An amendment to the SC 13G filing	Other	0000080255-20-000949.pdf 0000080255-20-000949.rtf View HTML
10/13/2020	SC 13G/A	An amendment to the SC 13G filing	Other	0000080255-20-001664.pdf 0000080255-20-001664.rtf View HTML
02/05/2021	SC 13G/A	An amendment to the SC 13G filing	Other	0000834237-21-007539.pdf 0000834237-21-007539.rtf View HTML
02/08/2021	SC 13G/A	An amendment to the SC 13G filing	Other	0000315066-21-000889.pdf 0000315066-21-000889.rtf View HTML
02/10/2021	SC 13G/A	An amendment to the SC 13G filing	Other	0001104659-21-017563.pdf 0001104659-21-017563.rtf View HTML
02/16/2021	SC 13G/A	An amendment to the SC 13G filing	Other	0000080255-21-000942.pdf 0000080255-21-000942.rtf View HTML
05/30/2014	SD	Specialized Disclosure Report	Other	0001193125-14-219287.pdf 0001193125-14-219287.rtf 0001193125-14-219287.xls View HTML
05/29/2015	SD	Specialized Disclosure Report	Other	0001193125-15-206469.pdf 0001193125-15-206469.rtf 0001193125-15-206469.xls View HTML
05/26/2016	SD	Specialized Disclosure Report	Other	0001193125-16-603613.pdf 0001193125-16-603613.rtf 0001193125-16-603613.xls View HTML
05/24/2017	SD	Specialized Disclosure Report	Other	0001193125-17-181884.pdf 0001193125-17-181884.rtf 0001193125-17-181884.xls View HTML

Data provided by Kaleidoscope.

Investor Highlights

Meet Jonathan

Moments after crossing the finish line of a half marathon, Jonathan went into cardiac arrest due to a congenital defect in his artery.

Drone Delivery Capabilities

See how BD and WeRobotics worked to advance drones for healthcare in the Peruvian Amazon

AMR Leadership

BD solutions to combat antimicrobial resistance